SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
437.00    -6.00 (-1.35%)
Bid:
431.00
Ask:
443.00
Spread: 12.00 (2.784%)
Market Cap: £215.76m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Interim Management Statement

7 Oct 2013 07:00

RNS Number : 8214P
City of London Investment Group PLC
07 October 2013
 



7th October 2013

CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Company" or "the Group")

INTERIM MANAGEMENT STATEMENT

 

AGM Trading Update

City of London (LSE: CLIG), a leading emerging markets asset management group, provides an Interim Management Statement for the period 31st May 2013 to 30th September 2013. City of London's Annual General Meeting is being held today.

 

Funds under Management

As at 30th September 2013, FuM were US$3.4 billion (£2.1 billion). This compares to US$3.7 billion (£2.4 billion) at the Company's year-end on 31st May 2013. In US dollar terms, allowing for client withdrawals, this represents a fall of 8% against the MSCI Emerging Markets Index, which fell by 1% over the same period. With the September reopening of the core emerging markets strategy we are able to report the first major mandate win, with expected funding in the fourth quarter of 2013.

 

Operations

The Group's income accrues at a weighted average rate of approximately 92 basis points, net of commissions. Costs remain under control with "fixed" costs in line with budget at £0.8 million per month, and accordingly the current run-rate for operating profit, before profit-share at 30%, is approximately £0.8 million per month based upon current FuM and a US$/£ exchange rate of US$1.6 to £1. The Group estimates that post-tax profit for the first four months of the year will be approximately £1.6 million.

We continue to raise the profile of the diversification products with prospects and consultants. This includes the China A Share CEF strategy, where we are awaiting approval for our second tranche of US$100 million in Qualified Foreign Institutional Investor quota.

 

Dividends

The final dividend of 16 pence per share, subject to approval at today's AGM, will be paid on 25th October 2013, bringing the total dividend for the financial year 2012-13 to 24 pence. Encouraged by both recent marketing success and a recovery in emerging markets, the Board is hopeful that run-rate profits will be sufficient to maintain the dividend during the current year, although this is likely to require a continued relaxation of the Group's 1.5 x dividend cover policy.

 

Remuneration Policy

The Board is aware of understandable concerns by shareholders with regard to the firm's remuneration policy.

Firstly as regards the compensation payments paid to the former CEO and FD, these were made after very extensive consultation and negotiation and were, in the unanimous opinion of the Board, made in the best interests of the company and its shareholders. Regrettably the Compromise Agreements entered into prevent the disclosure of any further information in connection with those payments. 

Secondly, as regards the firm's ESOP programme, the Board is again unanimous that it is in the best interests of CLIG. It should be noted that the shares issued are non-dilutive as they are purchased in the market, no new shares are issued, and, most importantly, our clients continue to emphasise the desirability of significant staff participation in the equity of CLIG.

 

Board composition

As previously announced, Barry Aling joined the Board on 1st August 2013. He has assumed the role of Audit Committee Chair. Allan Bufferd is the Senior Independent Director and Chairs the Remuneration Committee. Rian Dartnell is the Nominations Committee Chair.

 

Half year results for the six months to 30th November 2013 will be announced on 20th January 2014.

 

 

For further information please visit www.citlon.co.uk or contact:

Barry Olliff (CEO)

City of London Investment Group PLC

Tel: 001 610 380 2911

 

 Martin Green

 Canaccord Genuity Limited

 Financial Adviser & Broker

Tel: +44 (0)20 7523 8000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMGGVDFGFZM
Date   Source Headline
5th Dec 20117:00 amRNSFunds under Management, Trading Update
2nd Dec 201112:30 pmRNSResponse to Statement by City of London
1st Dec 20119:38 amRNSSupport for Capital Return Programme
1st Dec 20117:00 amRNSSupport for Capital Return Programme
2nd Nov 20112:19 pmRNSHolding(s) in Company
25th Oct 20114:39 pmRNSHolding(s) in Company
17th Oct 201112:57 pmRNSHolding(s) in Company - Replacement
11th Oct 201112:11 pmRNSTR1 Form
5th Oct 20111:27 pmRNSPDMR Transaction
4th Oct 20114:26 pmRNSResult of AGM
3rd Oct 20117:00 amRNSInterim Management Statement
8th Sep 20117:00 amRNSDirector/PDMR Shareholding
6th Sep 20117:00 amRNSFinal Results
22nd Aug 201112:52 pmRNSNotice of Results
20th Jul 201112:00 pmRNSHolding(s) in Company
4th Jul 201111:49 amRNSBlocklisting Interim Review
6th Jun 20112:57 pmRNSHolding(s) in Company
3rd Jun 20117:00 amRNSAppointment of Non-Executive Director
17th May 20115:12 pmRNSHolding(s) in Company
15th Apr 20112:25 pmRNSHolding(s) in Company
16th Mar 20119:07 amRNSDirector/PDMR Shareholding
8th Mar 201112:14 pmRNSHolding(s) in Company
7th Mar 20117:00 amRNSInterim Management Statement
15th Feb 20112:52 pmRNSHolding(s) in Company
14th Feb 20113:40 pmRNSDirector/PDMR Shareholding
3rd Feb 20119:22 amRNSDirector/PDMR Shareholding
31st Jan 20117:00 amRNSTotal Voting Rights
24th Jan 20112:58 pmRNSHolding(s) in Company
24th Jan 20117:00 amRNSHalf Yearly Report
4th Jan 20117:00 amRNSBlocklisting Interim Review
16th Dec 20104:01 pmRNSHolding(s) in Company
10th Dec 20103:44 pmRNSEndowment of Foundation by Executive Director
10th Dec 201011:01 amRNSLetter to Edinburgh Dragon
6th Dec 20107:00 amRNSFunds under Management & Trading Update
4th Nov 20104:32 pmRNSDirector/PDMR Shareholding
29th Oct 20108:10 amRNSCommencement of Trading on the Official List
26th Oct 20103:54 pmRNSPublication of Prospectus
26th Oct 20103:54 pmRNSPublication of Prospectus
25th Oct 20107:00 amRNSAGM Trading Update
25th Oct 20107:00 amRNSAGM Trading Update
19th Oct 201010:52 amRNSDirector/PDMR Shareholding
5th Oct 20104:57 pmRNSHolding(s) in Company
4th Oct 201010:43 amRNSHolding(s) in Company
1st Oct 20107:00 amRNSMove to the Official List and directors' dealings
16th Sep 20104:21 pmRNSDirector/PDMR Shareholding
16th Sep 20102:34 pmRNSHolding(s) in Company
15th Sep 20107:00 amRNSDirector/PDMR Shareholding
13th Sep 20107:00 amRNSFinal Results
25th Aug 20104:20 pmRNSHolding(s) in Company
23rd Aug 201011:37 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.